Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-07-23, Stock:JNJ, The news for the past five days is as follows:
2019-07-16: NEWS1: Johnson & Johnson Earnings: JNJ Stock Dips Despite Q2 Beat, Raised Guidance.NEWS2: Johnson & Johnson Earnings: JNJ Stock Dips Despite Q2 Beat, Raised Guidance.NEWS3: Johnson & Johnson (JNJ) Q2 2019 Earnings Call Transcript.NEWS4: Johnson & Johnson (JNJ) Q2 2019 Earnings Call Transcript.NEWS5: Johnson & Johnson Registers 2nd-Quarter Earnings Beat.NEWS6: Here's Why J&J Stock Is Sliding Despite A Second-Quarter Beat.NEWS7: US STOCKS-Wall Street slips as bank earnings, Trump trade comments weigh.NEWS8: Stocks close down after Trump says ‘a long way to go’ on trade and investors digest bank earnings.NEWS9: Health Care Sector Update for 07/16/2019: ONCS,CGIX,IDXG,GNMX,JNJ.NEWS10: Health Care Sector Update for 07/16/2019: ONCS,CGIX,IDXG,GNMX,JNJ.NEWS11: Johnson & Johnson CFO on the opioid crisis: 'We don’t believe we were the cause'.NEWS12: Dow Jones Today: Earnings Disappointments.NEWS13: Stocks slip slightly amid trade remarks, earnings season.NEWS14: US STOCKS-S&P 500 edges lower after mixed bank earnings, Trump comments.NEWS15: Johnson & Johnson (JNJ) Q2 2019 Earnings Call Transcript.NEWS16: J&J Ups Sales Forecast as Cancer Drugs Drive Growth.NEWS17: Health Care Sector Update for 07/16/2019: CGIX,IDXG,GNMX,JNJ.NEWS18: Health Care Sector Update for 07/16/2019: CGIX,IDXG,GNMX,JNJ.NEWS19: Stocks slip after Trump says ‘a long way to go’ on trade and investors digest bank earnings.NEWS20: What Q2 Johnson & Johnson earnings display about the company's future.NEWS21: Here's Why J&J Stock Is Sliding Despite A Second-Quarter Beat.NEWS22: J&J stock falls despite earnings beat and guidance boost.NEWS23: US Stocks Little Moved as Earnings Roll In Tuesday.NEWS24: US STOCKS-Wall Street edges lower after mixed bank earnings, Trump comments.NEWS25: Johnson & Johnson Earnings: JNJ Stock Dips Despite Q2 Beat, Raised Guidance.NEWS26: Better-Than Expected Retail Sales in June.NEWS27: Better-Than Expected Retail Sales in June.NEWS28: AbbVie (ABBV) Acquires Mavupharma to Boost Cancer Portfolio.NEWS29: AbbVie (ABBV) Acquires Mavupharma to Boost Cancer Portfolio.NEWS30: Dow Analyst Moves: JNJ.NEWS31: Dow Analyst Moves: JNJ.NEWS32: Johnson & Johnson Jumps on Earnings Beat.NEWS33: Stocks slip to near session lows after Trump says ‘a long way to go’ on trade.NEWS34: J&J (JNJ) Beats on Q2 Earnings, Ups 2019 Sales Growth View.NEWS35: J&J (JNJ) Beats on Q2 Earnings, Ups 2019 Sales Growth View.NEWS36: Retail Sales Up, Import Prices Down, Q2 Earnings Solid.NEWS37: Retail Sales Up, Import Prices Down, Q2 Earnings Solid.NEWS38: Stocks waver, Dow hits new intraday high as investors parse trio of bank earnings.NEWS39: UPDATE 2-Johnson & Johnson beats profit estimates on pharma strength, raises sales outlook.NEWS40: AbbVie (ABBV) Acquires Mavupharma to Boost Cancer Portfolio.NEWS41: US STOCKS-Wall Street muted after mixed bank earnings.NEWS42: Better-Than Expected Retail Sales in June.NEWS43: J&J (JNJ) Beats on Q2 Earnings, Ups 2019 Sales Growth View.NEWS44: Johnson & Johnson (JNJ) Tops Q2 Earnings and Revenue Estimates.NEWS45: Johnson & Johnson (JNJ) Tops Q2 Earnings and Revenue Estimates.NEWS46: Dow Jones Leads Stock Market Action, As Three Blue Chip Stocks Report Earnings.NEWS47: Retail Sales Up, Import Prices Down, Q2 Earnings Solid.NEWS48: Mostly Strong Results For Big Banks, And J&J Another Solid Earnings Performer.NEWS49: Goldman's stock rally helps keep Dow positive.NEWS50: Goldman&apos;s stock rally helps keep Dow positive.NEWS51: Dow hits new intraday high as investors parse trio of bank earnings.NEWS52: Health Care Sector Update for 07/16/2019: IMRN, MLNT, JNJ, PFE, ABT, MRK, AMGN.NEWS53: Health Care Sector Update for 07/16/2019: IMRN, MLNT, JNJ, PFE, ABT, MRK, AMGN.NEWS54: US STOCKS-Futures flat after JPMorgan results; Goldman Sachs, Wells Fargo eyed.NEWS55: US STOCKS-Wall Street set for subdued open after mixed bank reports.NEWS56: Stocks Open Lower As Dow Jones Stocks Goldman, J&J and JPMorgan Report.NEWS57: Stocks pull back from record levels as earnings season picks up steam.NEWS58: 3 Dow Leaders with Double-Digit Upside.NEWS59: 3 Dow Leaders with Double-Digit Upside.NEWS60: Stocks - JP Morgan, Wells Fargo Fall Premarket; J&J, Goldman Sachs Rise.NEWS61: Johnson & Johnson’s Earnings Beat Estimates, but the Stock Isn’t Taking Off.NEWS62: Johnson & Johnson (JNJ) Tops Q2 Earnings and Revenue Estimates.NEWS63: Johnson & Johnson beats profit estimates on pharma strength, raises sales outlook.NEWS64: J&J beats Wall Street expectations for second-quarter earnings, boosts guidance.NEWS65: Stock Futures Climb As Dow Jones Stocks Goldman, J&J and JPMorgan Report.NEWS66: The 2 Safest Dividend Stocks on the Planet.NEWS67: The 2 Safest Dividend Stocks on the Planet.NEWS68: Dow Jones Futures: Facebook Libra Unites Washington; Dow Stocks JPMorgan, Goldman Sachs, J&J Report.NEWS69: U.S. stocks set to tread water as investors parse trio of bank earnings.NEWS70: Shares of J&J up 0.8% after earnings and revenue beat.NEWS71: Johnson & Johnson beats profit estimates on pharma strength, raises sales outlook.NEWS72: Dow Jones Stock J&J Earnings, Sales Top Views.NEWS73: Johnson & Johnson Reports 2019 Second-Quarter Results.NEWS74: Johnson & Johnson to Host Earnings Call.NEWS75: The 2 Safest Dividend Stocks on the Planet.NEWS76: [video]Johnson & Johnson Tops Q2 Earnings Estimate, Boosts 2019 Sales Forecast.NEWS77: Johnson & Johnson Lifts Sales Guidance After Q2 Earnings Beat.NEWS78: AstraZeneca's Farxiga Gets CRL from FDA for Type I Diabetes.NEWS79: AstraZeneca's Farxiga Gets CRL from FDA for Type I Diabetes.NEWS80: J&J Submits BLA for Subcutaneous Formulation of Darzalex.NEWS81: J&J Submits BLA for Subcutaneous Formulation of Darzalex.
2019-07-17: NEWS1: These 4 Medical Stocks Could Benefit From J&J Earnings — Here's Why.NEWS2: FlexShares Makes A Big Low Vol ETF Splash.NEWS3: After Earnings Beat, Wall Street Talks Johnson & Johnson Litigation Risk.NEWS4: Healthcare ETFs in Focus on JNJ's Q2 Earnings Beat.NEWS5: Healthcare ETFs in Focus on JNJ's Q2 Earnings Beat.NEWS6: XLRE, SHE: Big ETF Inflows.NEWS7: XLRE, SHE: Big ETF Inflows.NEWS8: Company News for Jul 17, 2019.NEWS9: Company News for Jul 17, 2019.NEWS10: Healthcare ETFs in Focus on JNJ's Q2 Earnings Beat.NEWS11: Health Care Sector Update for 07/17/2019: GHSI, IMRN, ABT, JNJ, PFE, MRK, AMGN.NEWS12: Health Care Sector Update for 07/17/2019: GHSI, IMRN, ABT, JNJ, PFE, MRK, AMGN.NEWS13: Company News for Jul 17, 2019.NEWS14: Zoetis Inc. (ZTS) Ex-Dividend Date Scheduled for July 18, 2019.NEWS15: Zoetis Inc. (ZTS) Ex-Dividend Date Scheduled for July 18, 2019.NEWS16: WHO declares emergency over Ebola epidemic in Congo.NEWS17: Opioid makers dumped 76 billion pills onto U.S. market over 7 critical years, data shows.NEWS18: Dow Jones Today: Earnings Disappointments.NEWS19: Dow Jones Today: Earnings Disappointments.
2019-07-18: NEWS1: 3 Key Takeaways From J&J's (JNJ) Q2 Earnings Announcement.NEWS2: 3 Key Takeaways From J&J's (JNJ) Q2 Earnings Announcement.NEWS3: 3 Key Takeaways From J&J's (JNJ) Q2 Earnings Announcement.NEWS4: Top Stock Reports for Johnson & Johnson, NextEra & Deere.NEWS5: Top Stock Reports for Johnson & Johnson, NextEra & Deere.NEWS6: Jim Cramer: Looking for Netflix Action? Don't Be a Hero.NEWS7: Top Stock Reports for Johnson & Johnson, NextEra & Deere.NEWS8: 5 Signs of Life in Johnson & Johnson's Second-Quarter Earnings Report.NEWS9: 5 Signs of Life in Johnson & Johnson's Second-Quarter Earnings Report.NEWS10: Litigation Looms in the Wake of JNJ’s Solid Q2 Earnings.NEWS11: Health Care Sector Update for 07/18/2019: CODX, IDXG, NVS, JNJ, PFE, ABT, MRK, AMGN.NEWS12: Health Care Sector Update for 07/18/2019: CODX, IDXG, NVS, JNJ, PFE, ABT, MRK, AMGN.NEWS13: 5 Signs of Life in Johnson & Johnson&apos;s Second-Quarter Earnings Report.
2019-07-19: NEWS1: Noteworthy Friday Option Activity: INTC, BGS, JNJ.NEWS2: Noteworthy Friday Option Activity: INTC, BGS, JNJ.NEWS3: Edited Transcript of JNJ earnings conference call or presentation 16-Jul-19 12:30pm GMT.NEWS4: The Zacks Analyst Blog Highlights: Johnson & Johnson, NextEra, Deere, Cintas and Canadian Pacific.NEWS5: The Zacks Analyst Blog Highlights: Johnson & Johnson, NextEra, Deere, Cintas and Canadian Pacific.NEWS6: Pharma Stock Roundup: JNJ & NVS' Q2 Earnings, Pipeline/Regulatory Updates in Focus.NEWS7: Pharma Stock Roundup: JNJ & NVS' Q2 Earnings, Pipeline/Regulatory Updates in Focus.NEWS8: The Zacks Analyst Blog Highlights: Johnson & Johnson, NextEra, Deere, Cintas and Canadian Pacific.NEWS9: Intuitive Surgical's Q2 Performance Lauded By Bullish Analysts.NEWS10: Pharma Stock Roundup: JNJ & NVS' Q2 Earnings, Pipeline/Regulatory Updates in Focus.NEWS11: Health Care Sector Update for 07/19/2019: MTP, ATRA, IFRX, JNJ, ABT, MRK, PFE, AMGN.NEWS12: Health Care Sector Update for 07/19/2019: MTP, ATRA, IFRX, JNJ, ABT, MRK, PFE, AMGN.NEWS13: Dow 30 Stock Roundup: MSFT, JPM, IBM, JNJ, GS Earnings Impress.
2019-07-22: NEWS1: The 10 Biggest Blue Chip Stocks.NEWS2: The 10 Biggest Blue Chip Stocks.NEWS3: The Zacks Analyst Blog Highlights: Microsoft, JPMorgan, Merck, Johnson & Johnson and IBM.NEWS4: The Zacks Analyst Blog Highlights: Microsoft, JPMorgan, Merck, Johnson & Johnson and IBM.NEWS5: Relative Strength Alert For Johnson & Johnson.NEWS6: Relative Strength Alert For Johnson & Johnson.NEWS7: The 10 Biggest Blue Chip Stocks.NEWS8: J&J in hot water after safety lawsuits over baby powder.NEWS9: Johnson & Johnson faces more than 14k lawsuits over talc products.NEWS10: The Zacks Analyst Blog Highlights: Microsoft, JPMorgan, Merck, Johnson & Johnson and IBM.NEWS11: Companies to Watch: Equifax settles, CBS goes dark on AT&T, Vail buying Peak in ski deal.NEWS12: Companies to Watch: Equifax settles, CBS goes dark on AT&T, Vail buying Peak in ski deal.NEWS13: UPDATE 3-Congo minister's resignation over Ebola snub could unblock new vaccine.NEWS14: Is a Beat in Store for AbbVie (ABBV) This Earnings Season?.NEWS15: Stocks Slip This Week on Earnings, Fed Uncertainties.NEWS16: Is Johnson & Johnson a Buy?.

Answer: Rise